CEPI commits $4.17m to study vaccine protection against Ebola virus
They will examine which vaccines potentially provide cross-protection against Bundibugyo virus and identify vaccination regimens that might be associated with broad and durable cross-reactive immune responses,” CEPI noted.
The studies will also help establish and standardise antibody tests for Bundibugyo virus and examine how long such immune responses last.
The MRC-University of Glasgow Centre for Virus Research will receive $120,000 to study samples from vaccinated close contacts and Ugandan healthcare workers.
This is a summary of the original articles listed below. Always read the source articles for the full context. GhanaSummary does not create or modify the news — we summarise and link to original publishers.
